Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04066959 · ClinicalTrials.gov registry record · NA

Improving Diabetes in Emerging Adulthood

A NA study, sponsored by Wayne State University.

Completed
Registry status
NA
Development phase
113
Enrollment target

NCT04066959: Completed NA study, sponsored by Wayne State University.

NCT04066959 is a NA study that has completed, run by Wayne State University. The registered enrollment target is 113 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04066959, a NA study, has completed, sponsored by Wayne State University.

COMPLETED
Registry status
NA
Development phase
113 participants
Enrollment target

Study Summary

This project will test the efficacy of a multi-component behavioral intervention to improve metabolic control among older adolescents and emerging adults (16-21) with T1D, a group with chronic poor metabolic control. This intervention is grounded in self-determination theory which states that a youth who believes their diabetes management is self-directed, competent, and supported by others is more likely to consistently complete their diabetes self-care. This theory-driven intervention will be scalable to a variety of chronic illness contexts and the knowledge gained from this research will inform self-determination theory and different interventions targeting this population (currently there are no interventions that directly target emerging adults).

Primary Outcome

Hb1Ac will be obtained by using the Accubase A1c test kit.

Interventions

  • BEHAVIORAL Motivational Enhancement System (MES)
  • BEHAVIORAL Question Prompt List (QPL)
  • BEHAVIORAL Text Message Reminders (TXT)

Trial Details

FieldValue
Enrollment Target 113 participants
Start Date 2020-11-16
Est. Completion 2025-01-13
Phase NA
Wayne State University

163 total trials

What the finished NCT04066959 record still lists

NCT04066959 is an interventional study that assigns participants to a tested intervention. The registered 113 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 3 interventions - of which Motivational Enhancement System (MES) is the first listed.

NCT04066959 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04066959 about?

NCT04066959 is a clinical study titled "Improving Diabetes in Emerging Adulthood". This project will test the efficacy of a multi-component behavioral intervention to improve metabolic control among older adolescents and emerging adults (16-21) with T1D, a group with chronic poor metabolic control. This intervention is grounded in self-determination theory which states that a yout...

What is the current status of trial NCT04066959?

This trial is currently completed. It is a NA study. The enrollment target is 113 participants. The study started on 2020-11-16. Estimated completion is 2025-01-13.

What interventions are being tested in trial NCT04066959?

The interventions under investigation include: Motivational Enhancement System (MES) (BEHAVIORAL), Question Prompt List (QPL) (BEHAVIORAL), Text Message Reminders (TXT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04066959?

This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04066959's enrollment target sits among peer trials

113 813th of 2000 higher than 1,188 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00748254 · 113 participants

    Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis

  • NCT04753190 · 113 participants · NA

    Light Timing Study

  • NCT05799248 · 113 participants · Phase 3

    Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management

  • NCT07216105 · 113 participants · Phase 1

    FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04066959, the US trial registry maintained by the National Library of Medicine. NCT04066959 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.